Moreover, the inflammatory mediator, IL‐6, can induce MKs to proliferate and differentiate into mature PLTs after COVID‐19 and also can enhance the viability of MKs, thereby increasing PLT counts [13]. This evidence concerns the gene IL6 and COVID-19.